Don't underestimate the value of Wall Street sponsorship. I actually agree with you to some degree...I would rather invest in unnoticed, undercapitalized companies. Also, the following are VERY IMPORTANT in order for a company like this to get noticed:
(from my criteria, see supporting info at bottom)
2) Partnerships.
3) Milestones, and milestone payments.
6) Balance sheet. Are they strapped for cash?
Please note, CEGE only very recently got re-noticed by analysts. Moreover, analyst coverage is the first step to attracting "big money" to a company.
Let me let you guys in on a little information...
Some of you may know that I have had a few articles published on Silicon Investor. Also, recently I wrote a story on Monsanto and Cell Genesys which was circulated. Well, that article caught the attention of a "Vice President of Investments" at a fairly well-known firm. He was very interested (and was placing clients in the stock) but was most concerned about the cash position of the company. Now, that was *right before* the major news concerning the new funding from Japan Tobacco...I'm sure he is putting even more clients into the stock now.
Big money will continue to pick up this stock over the next few years...the company is now well-funded...this is CRITICAL.
"The key financial terms include payments to Cell Genesys of $12.7 million at signature, $2.5 million at first anniversary, up to $27.5 million in research and development funding during the first three years, up to $80 million in milestone payments and loans up to $30 million for Phase III trials. Of these total payments, Cell Genesys is expected to receive approximately $45 million during the first two years of the agreement."
From:
cellgenesys.com |
